T2 Biosystms Stock Alpha and Beta Analysis

TTOO Stock  USD 0.51  0.08  18.60%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as T2 Biosystms. It also helps investors analyze the systematic and unsystematic risks associated with investing in T2 Biosystms over a specified time horizon. Remember, high T2 Biosystms' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to T2 Biosystms' market risk premium analysis include:
Beta
0.41
Alpha
(3.00)
Risk
6.1
Sharpe Ratio
(0.46)
Expected Return
(2.78)
Please note that although T2 Biosystms alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, T2 Biosystms did 3.00  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of T2 Biosystms stock's relative risk over its benchmark. T2 Biosystms has a beta of 0.41  . As returns on the market increase, T2 Biosystms' returns are expected to increase less than the market. However, during the bear market, the loss of holding T2 Biosystms is expected to be smaller as well. As of the 22nd of November 2024, Enterprise Value is likely to grow to about 75.5 M, while Book Value Per Share is likely to drop (11.28).

Enterprise Value

75.45 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out T2 Biosystms Backtesting, T2 Biosystms Valuation, T2 Biosystms Correlation, T2 Biosystms Hype Analysis, T2 Biosystms Volatility, T2 Biosystms History and analyze T2 Biosystms Performance.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

T2 Biosystms Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. T2 Biosystms market risk premium is the additional return an investor will receive from holding T2 Biosystms long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in T2 Biosystms. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate T2 Biosystms' performance over market.
α-3   β0.41

T2 Biosystms expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of T2 Biosystms' Buy-and-hold return. Our buy-and-hold chart shows how T2 Biosystms performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

T2 Biosystms Market Price Analysis

Market price analysis indicators help investors to evaluate how T2 Biosystms stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading T2 Biosystms shares will generate the highest return on investment. By understating and applying T2 Biosystms stock market price indicators, traders can identify T2 Biosystms position entry and exit signals to maximize returns.

T2 Biosystms Return and Market Media

The median price of T2 Biosystms for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 1.63 with a coefficient of variation of 53.31. The daily time series for the period is distributed with a sample standard deviation of 0.94, arithmetic mean of 1.77, and mean deviation of 0.78. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of tradable shares by Elsbree David B of T2 Biosystms at 2.42 subject to Rule 16b-3
09/13/2024
2
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
09/16/2024
3
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
10/08/2024
4
Curiox Biosystems Co., Ltds market cap up 49b last week, benefiting both retail investors who own 56 percent as well as insiders
10/11/2024
5
Rapid Micro Biosystems earnings missed by 0.01, revenue topped estimates
11/01/2024
6
Disposition of 3100836 shares by Cr Group L.p. of T2 Biosystms at 0.3106 subject to Rule 16b-3
11/04/2024
7
Turning waste into fuel Bourbon industry offers new path for renewable energy
11/12/2024
8
T2 Biosystems Announces Third Quarter 2024 Financial Results
11/14/2024
9
T2 Biosystems Inc Q3 2024 Earnings Call Highlights Revenue Surge and Strategic ...
11/15/2024
10
Epicore Biosystems Named to Fast Companys Fourth Annual List of the Next Big Things in Tech
11/19/2024

About T2 Biosystms Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including TTOO or other stocks. Alpha measures the amount that position in T2 Biosystms has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Payables Turnover7.3116.3110.0614.63
Days Of Inventory On Hand68.9275.09114.49120.22

T2 Biosystms Upcoming Company Events

As portrayed in its financial statements, the presentation of T2 Biosystms' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, T2 Biosystms' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of T2 Biosystms' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of T2 Biosystms. Please utilize our Beneish M Score to check the likelihood of T2 Biosystms' management manipulating its earnings.
11th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with T2 Biosystms

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:
Check out T2 Biosystms Backtesting, T2 Biosystms Valuation, T2 Biosystms Correlation, T2 Biosystms Hype Analysis, T2 Biosystms Volatility, T2 Biosystms History and analyze T2 Biosystms Performance.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
T2 Biosystms technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of T2 Biosystms technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of T2 Biosystms trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...